Comparative Evaluation of Three Pulpotomy Agents for Permanent Mature Molars With Irreversible Pulpitis
Sponsored by Ain Shams University
About this trial
Last updated a year ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Started a year ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Participants with permanent molars considered as having clinical signs and symptoms consistent with a diagnosis of irreversible pulpitis if they presented with the following chief complaint:
- Intermittent or spontaneous, sharp or dull, localized, diffuse, or referred pain.
- Rapid exposure to dramatic temperature changes elicited heightened and --prolonged episodes of pain even after the thermal stimulus has been removed.
- Participants without signs and symptoms of apical periodontitis
- Periodontally healthy permanent molars
- Systemically healthy patients without any history of long-acting NSAIDs intake in the past one week will be included to eliminate any confounding factors.
Exclusion Criteria
- Non-restorable teeth with cracks or subgingival caries, associated sinus or swelling, immature roots, periapical rarefaction (PAI score ≥ 3).
- Poor periodontal support.
- Negative response to pulp sensibility tests.
- Diabetic, immune-compromised, pregnant patients
- Patient had a positive history of antibiotic use in the past 1 month or required antibiotic prophylaxis
- The tooth was previously accessed
- The tooth had an inflamed pulp in which bleeding could not be controlled within 10 minutes.